| pubmed-article:9879292 | rdf:type | pubmed:Citation | lld:pubmed |
| pubmed-article:9879292 | lifeskim:mentions | umls-concept:C0030705 | lld:lifeskim |
| pubmed-article:9879292 | lifeskim:mentions | umls-concept:C0087111 | lld:lifeskim |
| pubmed-article:9879292 | lifeskim:mentions | umls-concept:C1518578 | lld:lifeskim |
| pubmed-article:9879292 | lifeskim:mentions | umls-concept:C0149925 | lld:lifeskim |
| pubmed-article:9879292 | lifeskim:mentions | umls-concept:C0442027 | lld:lifeskim |
| pubmed-article:9879292 | lifeskim:mentions | umls-concept:C0008838 | lld:lifeskim |
| pubmed-article:9879292 | lifeskim:mentions | umls-concept:C0015133 | lld:lifeskim |
| pubmed-article:9879292 | lifeskim:mentions | umls-concept:C0022341 | lld:lifeskim |
| pubmed-article:9879292 | lifeskim:mentions | umls-concept:C0205179 | lld:lifeskim |
| pubmed-article:9879292 | lifeskim:mentions | umls-concept:C1274034 | lld:lifeskim |
| pubmed-article:9879292 | pubmed:issue | 12 | lld:pubmed |
| pubmed-article:9879292 | pubmed:dateCreated | 1999-1-11 | lld:pubmed |
| pubmed-article:9879292 | pubmed:abstractText | Etoposide is a highly schedule-dependent drug. We investigated combination chemotherapy of oral etoposide and intravenous cisplatin for small cell lung cancer (SCLC). | lld:pubmed |
| pubmed-article:9879292 | pubmed:language | eng | lld:pubmed |
| pubmed-article:9879292 | pubmed:journal | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:9879292 | pubmed:citationSubset | IM | lld:pubmed |
| pubmed-article:9879292 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:9879292 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:9879292 | pubmed:status | MEDLINE | lld:pubmed |
| pubmed-article:9879292 | pubmed:month | Dec | lld:pubmed |
| pubmed-article:9879292 | pubmed:issn | 0368-2811 | lld:pubmed |
| pubmed-article:9879292 | pubmed:author | pubmed-author:TamuraTT | lld:pubmed |
| pubmed-article:9879292 | pubmed:author | pubmed-author:KuboSS | lld:pubmed |
| pubmed-article:9879292 | pubmed:author | pubmed-author:ShimoyamaMM | lld:pubmed |
| pubmed-article:9879292 | pubmed:author | pubmed-author:KawaharaMM | lld:pubmed |
| pubmed-article:9879292 | pubmed:author | pubmed-author:SaijoNN | lld:pubmed |
| pubmed-article:9879292 | pubmed:author | pubmed-author:FuruseKK | lld:pubmed |
| pubmed-article:9879292 | pubmed:author | pubmed-author:AsamotoHH | lld:pubmed |
| pubmed-article:9879292 | pubmed:author | pubmed-author:IwamiFF | lld:pubmed |
| pubmed-article:9879292 | pubmed:issnType | Print | lld:pubmed |
| pubmed-article:9879292 | pubmed:volume | 28 | lld:pubmed |
| pubmed-article:9879292 | pubmed:owner | NLM | lld:pubmed |
| pubmed-article:9879292 | pubmed:authorsComplete | Y | lld:pubmed |
| pubmed-article:9879292 | pubmed:pagination | 745-8 | lld:pubmed |
| pubmed-article:9879292 | pubmed:dateRevised | 2006-11-15 | lld:pubmed |
| pubmed-article:9879292 | pubmed:meshHeading | pubmed-meshheading:9879292-... | lld:pubmed |
| pubmed-article:9879292 | pubmed:meshHeading | pubmed-meshheading:9879292-... | lld:pubmed |
| pubmed-article:9879292 | pubmed:meshHeading | pubmed-meshheading:9879292-... | lld:pubmed |
| pubmed-article:9879292 | pubmed:meshHeading | pubmed-meshheading:9879292-... | lld:pubmed |
| pubmed-article:9879292 | pubmed:meshHeading | pubmed-meshheading:9879292-... | lld:pubmed |
| pubmed-article:9879292 | pubmed:meshHeading | pubmed-meshheading:9879292-... | lld:pubmed |
| pubmed-article:9879292 | pubmed:meshHeading | pubmed-meshheading:9879292-... | lld:pubmed |
| pubmed-article:9879292 | pubmed:meshHeading | pubmed-meshheading:9879292-... | lld:pubmed |
| pubmed-article:9879292 | pubmed:meshHeading | pubmed-meshheading:9879292-... | lld:pubmed |
| pubmed-article:9879292 | pubmed:meshHeading | pubmed-meshheading:9879292-... | lld:pubmed |
| pubmed-article:9879292 | pubmed:meshHeading | pubmed-meshheading:9879292-... | lld:pubmed |
| pubmed-article:9879292 | pubmed:meshHeading | pubmed-meshheading:9879292-... | lld:pubmed |
| pubmed-article:9879292 | pubmed:meshHeading | pubmed-meshheading:9879292-... | lld:pubmed |
| pubmed-article:9879292 | pubmed:meshHeading | pubmed-meshheading:9879292-... | lld:pubmed |
| pubmed-article:9879292 | pubmed:meshHeading | pubmed-meshheading:9879292-... | lld:pubmed |
| pubmed-article:9879292 | pubmed:meshHeading | pubmed-meshheading:9879292-... | lld:pubmed |
| pubmed-article:9879292 | pubmed:meshHeading | pubmed-meshheading:9879292-... | lld:pubmed |
| pubmed-article:9879292 | pubmed:meshHeading | pubmed-meshheading:9879292-... | lld:pubmed |
| pubmed-article:9879292 | pubmed:meshHeading | pubmed-meshheading:9879292-... | lld:pubmed |
| pubmed-article:9879292 | pubmed:meshHeading | pubmed-meshheading:9879292-... | lld:pubmed |
| pubmed-article:9879292 | pubmed:meshHeading | pubmed-meshheading:9879292-... | lld:pubmed |
| pubmed-article:9879292 | pubmed:year | 1998 | lld:pubmed |
| pubmed-article:9879292 | pubmed:articleTitle | Cisplatin plus oral etoposide in the treatment of patients with advanced small cell lung cancer. Japan Clinical Oncology Group. | lld:pubmed |
| pubmed-article:9879292 | pubmed:affiliation | Department of Respiratory Diseases, Kyoto National Hospital, Japan. | lld:pubmed |
| pubmed-article:9879292 | pubmed:publicationType | Journal Article | lld:pubmed |
| pubmed-article:9879292 | pubmed:publicationType | Clinical Trial | lld:pubmed |
| pubmed-article:9879292 | pubmed:publicationType | Research Support, Non-U.S. Gov't | lld:pubmed |
| pubmed-article:9879292 | pubmed:publicationType | Multicenter Study | lld:pubmed |
